Insights and experience: navigating the diversity and complexity of mRNA-LNP approaches

David is an experienced biopharma professional with many years of industry experience. Dave joined PALL Corporation as an R&D engineer supporting the development of acoustic technologies, before moving into Project Management, and then into Global Product Management. He is an integral part of the cross-functional team between Cytiva, PALL, and PNI, created to design an integrated mRNA workflow.

Prior to his professional career, he acquired a B.S. in Microbiology from the University of Massachusetts, Amherst, which inspired him to join the UMass Med School PhD program investigating the post-transcriptional regulation of mRNA through RNA-binding protein interactions. Prior to completing his PhD, Dave chose to refocus his career towards scientific technology application development, and instead earned a B.S. in Mechanical Engineering from UMass Amherst.

Katarina Stenklo holds a licentiate degree in biochemistry and have over 20 years of industry experience. She currently works for Cytiva in the Manufacturing capacity solutions business unit. She has extensive expertise in developing end-to-end manufacturing solutions that includes process workflows, process equipment, automation, consumables, and facilities. Her focus over the last few years has been developing and designing solutions for the manufacture of new product modalities such as viral vectors, plasmids, and mRNA therapies.